RTL GROUP/ LU0061462528 /
28/05/2024 08:12:08 | Var. +0.150 | Volume | Denaro14:43:03 | Lettera14:43:03 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
29.450EUR | +0.51% | 0 Fatturato: 0.000 |
29.550Quantità in denaro: 500 | 29.650Quantità in lettera: 500 | 4.58 bill.EUR | 9.29% | 9.80 |
GlobeNewswire
14:53
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire
14:45
Wearable Devices XR Team's Report: The Mudra’s Neural Technology to Power Future XR Devices
GlobeNewswire
14:45
Aprea Therapeutics Announces that Safety Review Committee (SRC) Endorses Dosing of Patients with ATR...
GlobeNewswire
14:40
AITX’s RAD Announces First Paid Analytic based on Vast Improvements in Its Firearm Detection Speed &...
GlobeNewswire
14:39
Specialized Education Services, Inc. Unveils 2024 Staff and Teacher of the Year Winners
GlobeNewswire
14:31
Mama’s Creations to Host First Quarter and Fiscal Year 2025 Earnings Call on June 11 at 4:30 p.m. Ea...
GlobeNewswire
14:30
Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Press...
GlobeNewswire
14:30
Nano Dimension Is Partnering with Esko and Fiery to Provide an End-To-End Industry 4.0 Solution
GlobeNewswire
14:30
SRIVARU (SVMH) Announces the Completion of State-of-the-Art Factory and Fully Automated EV Motorcycl...
GlobeNewswire
14:30
GunBroker Partners with Gearfire Capital to Offer Innovative Financing Solutions for Firearms Retail...
GlobeNewswire
14:30
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Dist...
GlobeNewswire
14:30
NewGenIvf Receives Nasdaq Notifications Regarding Market Value of Publicly Held Shares and Market Va...
GlobeNewswire
14:30
Golden Triangle Ventures, Inc. Announces Strategic Agreement with T&K Zarro, LLC to Strengthen Capit...
GlobeNewswire
14:30
Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
GlobeNewswire
14:30
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depre...